GLP-1s and Kids: New Report Links Medications to Nutritional Deficiencies in Children
A new study suggests a link between GLP-1 weight loss and diabetes drugs and nutritional deficiencies in nearly 1 in 6 children.
A new report, highlighted recently by ScienceDaily, has brought an important conversation to the forefront for families: GLP-1 weight loss and diabetes medications may be linked to nutritional deficiencies in nearly 1 in 6 children using these drugs GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children. This finding comes from a recent study published in Childhood Obesity.
What the Research Shows
According to a study by Kerr et al. published in Child Obesity, pediatric patients using GLP-1 receptor agonists were found to have a notable incidence of nutritional deficiencies and other complications Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists. This research provides some of the first insights into the specific nutritional impacts these medications might have on younger individuals.
GLP-1 medications, like semaglutide (brand names such as Wegovy and Ozempic), work by mimicking a natural hormone that helps regulate appetite and blood sugar. For example, the FDA-approved label for Wegovy states it's indicated for use in pediatric patients aged 12 years and older with obesity, in combination with a reduced-calorie diet and increased physical activity FDA Wegovy Label. Ozempic, another semaglutide drug, is indicated for adults with type 2 diabetes FDA Ozempic Label.
Understanding the "Why"
So, why might these nutritional concerns arise? GLP-1 medications are known to cause gastrointestinal side effects. The FDA's label for Wegovy lists common adverse reactions in both adults and pediatric patients aged 12 years and older, including nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, and decreased appetite FDA Wegovy Label. Ozempic's label also lists nausea, abdominal pain, diarrhea, decreased appetite, and vomiting as common adverse reactions FDA Ozempic Label.
When you experience these side effects, especially a decreased appetite, it can naturally lead to eating less. Over time, consistently eating less or having frequent digestive upset could make it harder to get all the essential vitamins and minerals your body needs, potentially leading to deficiencies. MedlinePlus notes that maintaining a healthy weight involves a balance of diet and physical activity, and that some weight loss strategies can affect how you digest food and absorb nutrients MedlinePlus Weight Control.
What This Means For You
If you or a loved one, especially a child or adolescent, is using a GLP-1 medication, this new information highlights the importance of proactive monitoring and communication with your healthcare team.
- Open Communication: Talk to your prescriber about any side effects you or your child are experiencing, especially persistent nausea, vomiting, or changes in eating habits.
- Nutritional Support: Discuss strategies with your doctor or a registered dietitian to ensure adequate nutrient intake. This might involve focusing on nutrient-dense foods, or in some cases, considering supplements under medical guidance.
- Regular Monitoring: Ensure regular check-ups that include monitoring for potential nutritional deficiencies, as recommended by your healthcare provider.
Not medical advice. Talk to your prescriber about your situation.
